Effect of Amra-Lajadi Avleh in vomiting in pregnancy

A Study Of The Efficacy Of Amra-Lajadi Lehya In Garbhini-Chardi (Emesis Gravidarum)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054095

Enrollment

Registered

2023-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O210- Mild hyperemesis gravidarum

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a)Antenatal patients complaining of Nausea, vomiting. (b)Age group 18-35 years. (c)Both primi and multigravida patients. (d) Patient willing to sign the informed consent form. 3

Exclusion criteria

Exclusion criteria: (a)Patients with hyperemesis gravidarum. (b)Immuno-compromised patients. (c)Patients taking medicines for any other systemic illness. (d)Known case of HTN, GDM. (e)Vomiting due to other medical and surgical illnesses

Design outcomes

Primary

Measure	Time frame
Improvement in signs & symptoms of Garbhini Chardi- Nausea,Number of episodes of vomiting,headache,weaknessTimepoint: 7 days	—

Secondary

Measure	Time frame
Improvement in appetite and amount of intake.Timepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Rahul N Gajare

bharati vidyapeeth college of ayurved,pune

Drrahulngajare35@gmail.com9890506779

Outcome results